Prostaglandin Receptor EP4 Mediates the Bone Anabolic Effects of PGE2

xPharm- The Comprehensive Pharmacology Reference

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):
Year:		Vol:		Page:

This Article

	Full Text
	Full Text (PDF)
	An erratum has been published
	Submit a response
	Alert me when this article is cited
	Alert me when eLetters are posted
	Alert me if a correction is posted

Services

	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Machwate, M.
	Articles by Rodan, G. A.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Machwate, M.
	Articles by Rodan, G. A.

Vol. 60, Issue 1, 36-41, July 2001

Prostaglandin Receptor EP₄ Mediates the Bone Anabolic Effects of PGE₂

M. Machwate, S. Harada, C. T. Leu, G. Seedor, M. Labelle, M. Gallant, S. Hutchins, N. Lachance, N. Sawyer, D. Slipetz, K. M. Metters, S. B. Rodan, R. Young, and G. A. Rodan

Department of Bone Biology and Osteoporosis Research, Merck Research Laboratories, West Point, Pennsylvania (M.M., S.H., C.T.L., G.S., S.B.R., G.A.R.); and Merck Frosst, Kirkland, Quebec, Canada (M.L., M.G., S.H., N.L., N.S., D.S., K.M.M., R.Y.)

Prostaglandin (PG) E₂ is a potent inducer of cortical and trabecular bone formation in humans and animals. Although the boneanabolic action of PGE₂ is well documented, the cellular and molecularmechanisms that mediate this effect remain unclear. This studywas undertaken to examine the effect of pharmacological inactivationof the prostanoid receptor EP₄, one of the PGE₂ receptors, onPGE₂-induced bone formation in vivo. We first determined the abilityof EP₄A, an EP₄-selective ligand, to act as an antagonist. PGE₂increases intracellular cAMP and suppresses apoptosis in the RP-1periosteal cell line. Both effects were reversed by EP₄A, suggestingthat EP₄A acts as an EP₄ antagonist in the cells at concentrationsconsistent with its in vitro binding to EP₄. We then examinedthe effect of EP₄ on bone formation induced by PGE₂ in young rats.Five- to 6-week-old rats were treated with PGE₂ (6 mg/kg/day)in the presence or absence of EP₄A (10 mg/kg/day) for 12 days.We found that treatment with EP₄A suppresses the increase in trabecularbone volume induced by PGE₂. This effect is accompanied by a suppressionof bone formation indices: serum osteocalcin, extent of labeledsurface, and extent of trabecular number, suggesting that thereduction in bone volume is due most likely to decreased boneformation. The pharmacological evidence presented here providesstrong support for the hypothesis that the bone anabolic effectof PGE₂ in rats is mediated by the EP₄receptor.

This article has been cited by other articles:

S. Ramanadham, K. E. Yarasheski, M. J. Silva, M. Wohltmann, D. V. Novack, B. Christiansen, X. Tu, S. Zhang, X. Lei, and J. Turk
Age-Related Changes in Bone Morphology Are Accelerated in Group VIA Phospholipase A2 (iPLA2{beta})-Null Mice
Am. J. Pathol., April 1, 2008; 172(4): 868 - 881.
[Abstract] [Full Text] [PDF]

G. Elberg, D. Elberg, T. V. Lewis, S. Guruswamy, L. Chen, C. J. Logan, M. D. Chan, and M. A. Turman
EP2 receptor mediates PGE2-induced cystogenesis of human renal epithelial cells
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1622 - F1632.
[Abstract] [Full Text] [PDF]

U. C. Kopp, M. Z. Cicha, L. A. Smith, J. Mulder, and T. Hokfelt
Renal sympathetic nerve activity modulates afferent renal nerve activity by PGE2-dependent activation of {alpha}1- and {alpha}2-adrenoceptors on renal sensory nerve fibers
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1561 - R1572.
[Abstract] [Full Text] [PDF]

K. Nakao, A. Murase, H. Ohshiro, T. Okumura, K. Taniguchi, Y. Murata, M. Masuda, T. Kato, Y. Okumura, and J. Takada
CJ-023,423, a Novel, Potent and Selective Prostaglandin EP4 Receptor Antagonist with Antihyperalgesic Properties
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 686 - 694.
[Abstract] [Full Text] [PDF]

R. A. Bundey and P. A. Insel
Adenylyl Cyclase 6 Overexpression Decreases the Permeability of Endothelial Monolayers via Preferential Enhancement of Prostacyclin Receptor Function
Mol. Pharmacol., November 1, 2006; 70(5): 1700 - 1707.
[Abstract] [Full Text] [PDF]

L. G. Raisz
Selective Prostaglandin Agonists as Anabolic Agents
IBMS BoneKEy, July 1, 2006; 3(7): 15 - 20.
[Abstract] [Full Text] [PDF]

L. Aoudjit, A. Potapov, and T. Takano
Prostaglandin E2 promotes cell survival of glomerular epithelial cells via the EP4 receptor
Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1534 - F1542.
[Abstract] [Full Text] [PDF]

S. C. Manolagas
Choreography from the Tomb: An Emerging Role of Dying Osteocytes in the Purposeful, and Perhaps Not So Purposeful, Targeting of Bone Remodeling
IBMS BoneKEy, January 1, 2006; 3(1): 5 - 14.
[Full Text] [PDF]

M. Mendez and M. C. LaPointe
PGE2-induced hypertrophy of cardiac myocytes involves EP4 receptor-dependent activation of p42/44 MAPK and EGFR transactivation
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2111 - H2117.
[Abstract] [Full Text] [PDF]

D. L. Clarke, M. G. Belvisi, S. J. Smith, E. Hardaker, M. H. Yacoub, K. K. Meja, R. Newton, D. M. Slater, and M. A. Giembycz
Prostanoid receptor expression by human airway smooth muscle cells and regulation of the secretion of granulocyte colony-stimulating factor
Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L238 - L250.
[Abstract] [Full Text] [PDF]

D. L. Clarke, M. G. Belvisi, E. Hardaker, R. Newton, and M. A. Giembycz
E-Ring 8-Isoprostanes Are Agonists at EP2- and EP4-Prostanoid Receptors on Human Airway Smooth Muscle Cells and Regulate the Release of Colony-Stimulating Factors by Activating cAMP-Dependent Protein Kinase
Mol. Pharmacol., February 1, 2005; 67(2): 383 - 393.
[Abstract] [Full Text] [PDF]

U. C. Kopp, M. Z. Cicha, K. Nakamura, R. M. Nusing, L. A. Smith, and T. Hokfelt
Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nerves
Am J Physiol Renal Physiol, December 1, 2004; 287(6): F1269 - F1282.
[Abstract] [Full Text] [PDF]

C. H. Turner and A. G. Robling
Mechanical Loading and Bone Formation
IBMS BoneKEy, September 1, 2004; 1(9): 15 - 23.
[Abstract] [Full Text] [PDF]

E. Kuroda and U. Yamashita
Mechanisms of Enhanced Macrophage-Mediated Prostaglandin E2 Production and Its Suppressive Role in Th1 Activation in Th2-Dominant BALB/c Mice
J. Immunol., January 15, 2003; 170(2): 757 - 764.
[Abstract] [Full Text] [PDF]

K. Takayama, G. Garcia-Cardena, G. K. Sukhova, J. Comander, M. A. Gimbrone Jr., and P. Libby
Prostaglandin E2 Suppresses Chemokine Production in Human Macrophages through the EP4 Receptor
J. Biol. Chem., November 8, 2002; 277(46): 44147 - 44154.
[Abstract] [Full Text] [PDF]

K. Yoshida, H. Oida, T. Kobayashi, T. Maruyama, M. Tanaka, T. Katayama, K. Yamaguchi, E. Segi, T. Tsuboyama, M. Matsushita, et al.
Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation
PNAS, April 2, 2002; 99(7): 4580 - 4585.
[Abstract] [Full Text] [PDF]

K. Yoshida, H. Oida, T. Kobayashi, T. Maruyama, M. Tanaka, T. Katayama, K. Yamaguchi, E. Segi, T. Tsuboyama, M. Matsushita, et al.
Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation
PNAS, April 2, 2002; 99(7): 4580 - 4585.
[Abstract] [Full Text] [PDF]

				G. Elberg, D. Elberg, T. V. Lewis, S. Guruswamy, L. Chen, C. J. Logan, M. D. Chan, and M. A. Turman EP2 receptor mediates PGE2-induced cystogenesis of human renal epithelial cells Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1622 - F1632. [Abstract] [Full Text] [PDF]

				U. C. Kopp, M. Z. Cicha, L. A. Smith, J. Mulder, and T. Hokfelt Renal sympathetic nerve activity modulates afferent renal nerve activity by PGE2-dependent activation of {alpha}1- and {alpha}2-adrenoceptors on renal sensory nerve fibers Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1561 - R1572. [Abstract] [Full Text] [PDF]

				K. Nakao, A. Murase, H. Ohshiro, T. Okumura, K. Taniguchi, Y. Murata, M. Masuda, T. Kato, Y. Okumura, and J. Takada CJ-023,423, a Novel, Potent and Selective Prostaglandin EP4 Receptor Antagonist with Antihyperalgesic Properties J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 686 - 694. [Abstract] [Full Text] [PDF]

				R. A. Bundey and P. A. Insel Adenylyl Cyclase 6 Overexpression Decreases the Permeability of Endothelial Monolayers via Preferential Enhancement of Prostacyclin Receptor Function Mol. Pharmacol., November 1, 2006; 70(5): 1700 - 1707. [Abstract] [Full Text] [PDF]

				L. G. Raisz Selective Prostaglandin Agonists as Anabolic Agents IBMS BoneKEy, July 1, 2006; 3(7): 15 - 20. [Abstract] [Full Text] [PDF]

				L. Aoudjit, A. Potapov, and T. Takano Prostaglandin E2 promotes cell survival of glomerular epithelial cells via the EP4 receptor Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1534 - F1542. [Abstract] [Full Text] [PDF]

				S. C. Manolagas Choreography from the Tomb: An Emerging Role of Dying Osteocytes in the Purposeful, and Perhaps Not So Purposeful, Targeting of Bone Remodeling IBMS BoneKEy, January 1, 2006; 3(1): 5 - 14. [Full Text] [PDF]

				M. Mendez and M. C. LaPointe PGE2-induced hypertrophy of cardiac myocytes involves EP4 receptor-dependent activation of p42/44 MAPK and EGFR transactivation Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2111 - H2117. [Abstract] [Full Text] [PDF]

				D. L. Clarke, M. G. Belvisi, S. J. Smith, E. Hardaker, M. H. Yacoub, K. K. Meja, R. Newton, D. M. Slater, and M. A. Giembycz Prostanoid receptor expression by human airway smooth muscle cells and regulation of the secretion of granulocyte colony-stimulating factor Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L238 - L250. [Abstract] [Full Text] [PDF]

				D. L. Clarke, M. G. Belvisi, E. Hardaker, R. Newton, and M. A. Giembycz E-Ring 8-Isoprostanes Are Agonists at EP2- and EP4-Prostanoid Receptors on Human Airway Smooth Muscle Cells and Regulate the Release of Colony-Stimulating Factors by Activating cAMP-Dependent Protein Kinase Mol. Pharmacol., February 1, 2005; 67(2): 383 - 393. [Abstract] [Full Text] [PDF]

				U. C. Kopp, M. Z. Cicha, K. Nakamura, R. M. Nusing, L. A. Smith, and T. Hokfelt Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nerves Am J Physiol Renal Physiol, December 1, 2004; 287(6): F1269 - F1282. [Abstract] [Full Text] [PDF]

				C. H. Turner and A. G. Robling Mechanical Loading and Bone Formation IBMS BoneKEy, September 1, 2004; 1(9): 15 - 23. [Abstract] [Full Text] [PDF]

				E. Kuroda and U. Yamashita Mechanisms of Enhanced Macrophage-Mediated Prostaglandin E2 Production and Its Suppressive Role in Th1 Activation in Th2-Dominant BALB/c Mice J. Immunol., January 15, 2003; 170(2): 757 - 764. [Abstract] [Full Text] [PDF]

				K. Takayama, G. Garcia-Cardena, G. K. Sukhova, J. Comander, M. A. Gimbrone Jr., and P. Libby Prostaglandin E2 Suppresses Chemokine Production in Human Macrophages through the EP4 Receptor J. Biol. Chem., November 8, 2002; 277(46): 44147 - 44154. [Abstract] [Full Text] [PDF]

				K. Yoshida, H. Oida, T. Kobayashi, T. Maruyama, M. Tanaka, T. Katayama, K. Yamaguchi, E. Segi, T. Tsuboyama, M. Matsushita, et al. Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation PNAS, April 2, 2002; 99(7): 4580 - 4585. [Abstract] [Full Text] [PDF]